3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
NIH
2
OTHER
1
NETWORK
1
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
37
Gynecologic
2
Head & Neck
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Melanoma
1654
Skin Neoplasms
355
Lymphoma, T-Cell, Cutaneous
322
Carcinoma, Basal Cell
240
Mycosis Fungoides
227
Sezary Syndrome
209
Breast Neoplasms
196
Leukemia, Lymphocytic, Chronic, B-Cell
193
Lymphoma, Non-Hodgkin
192
Lymphoma, Follicular
187
Precursor Cell Lymphoblastic Leukemia-Lymphoma
183
Lymphoma, Large B-Cell, Diffuse
183
Lymphoma, B-Cell, Marginal Zone
182
Lymphoma, Mantle-Cell
181
Hodgkin Disease
175
Lymphoma
173
Burkitt Lymphoma
173
Uveal Melanoma
170
Lymphoma, Large-Cell, Immunoblastic
168
Multiple Myeloma
159
Keratosis, Actinic
146
Neoplasms
142
Leukemia, Myeloid, Acute
134
Neoplasm Metastasis
125
Lymphoma, Large-Cell, Anaplastic
125
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
123
Lung Neoplasms
120
Immunoblastic Lymphadenopathy
115
Leukemia, Myeloid, Accelerated Phase
113
Leukemia, Myeloid, Chronic-Phase
112
Interventions
Mohs Surgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Histiocytoma, Malignant Fibrous
×
Dermatologic
×
Clear all
NCT02310503
2020-05-05
REGESMOHS
Fundación Academia Española de Dermatología
Completed
6,000 enrolled